Roche Holding will halt two late-stage clinical trials of its crenezumab drug in early Alzheimer's disease after an interim analysis indicated it was unlikely to hits its primary goal, the Swiss drugmaker said on Wednesday.
from Latest News http://bit.ly/2RqpSUg
Roche drops Alzheimer drug trials after setback
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment